Source: Annual Congress 2010 - Idiopathic pulmonary fibrosis: present understandings and future directions
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
U. Costabel (Essen, Germany). Emerging Potential Treatments: new hope for patients?. Annual Congress 2010 - Idiopathic pulmonary fibrosis: present understandings and future directions

Member's Comments

No comment yet.

Related content which might interest you: Bronchiectasis: new therapies and perspectives Source: International Congress 2018 – Bronchiectasis: new insights in diagnosis and treatment Year: 2018 Asthma: still a promising future? Source: Eur Respir Rev 2014; 23: 405-407 Year: 2014 Outlook: what will the future bring? Source: Annual Congress 2012 - Autoimmunity in airways disease Year: 2012 Chronic cough: new insights and future prospects Source: Eur Respir Rev, 30 (162) 210127; 10.1183/16000617.0127-2021 Year: 2021 May 29: New opportunities for clinical research consortia in Severe Asthma and COPD and what is required of a successful Expression of Interest for the 2008 IMI calls? Source: Year: 2008 Filling in the gaps- Translational research to develop new therapies  Source: International Congress 2017 – Bronchiectasis: from guidelines to real life Year: 2017 Pharmacological treatment optimisation for stable COPD: an endless story? Source: Eur Respir J, 50 (4) 1701250; 10.1183/13993003.01250-2017 Year: 2017 Chronic cough: Are we integrating non-pharmacological therapies into treatment plans? Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017 Pharmacogenetics and asthma: false hope or new dawn? Source: Eur Respir J 2007; 29: 1239-1245 Year: 2007 Targeting mucus as a new therapeutic avenue? Source: Annual Congress 2011 - Mucus in airway diseases: bad or good partner? Year: 2011 Who should receive which biologic and why? Current and future approaches in severe asthma patients Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what? Year: 2021 Therapeutic strategies: what treatment for what patient Source: Annual Congress 2008 - PG12 - Challenges in pulmonary embolism: hot issues and interactive cases (jointly organised with ACCP) Year: 2008 Tuberculosis elimination, patients' lives and rational use of new drugs: revisited Source: Eur Respir J 2016; 47: 664-667 Year: 2016 Late Breaking Abstract - Implications of new PH definition for CTEPD Source: Virtual Congress 2021 – Therapy of pulmonary hypertension Year: 2021